On this therapy, patients routinely de-
velop a variety of symptoms, most commonly described as
“flu-like,” such as low-grade fevers, muscle aches and pains,
and even rashes that we hypothesize result from low-grade
tumor lysis
췌장소화효소를 복용하면 감기와 같은 '낮은 정도의 발열, 근육통, 관절통, rashes'증상이 2주정도 발생할 수 있음. - 명현반응으로...
효소를 췌장암 치료에서도 이용
특히 췌장암 치료는 Kelley-Gonzalez regimen 이라 불리는 켈리 대체의학 요법으로 이미 유명함
Dr.켈리는 췌장암의 원인중 하나가 췌장효소의 부족으로 인식 항암치료에 췌장효소를 보충해주는 형식으로 치료를 시도 많은 암환자를 치료함.
췌장효소에는 강력한 항암작용이 있다는 것을 미국콜롬비아 대학과 미국국립 암연구소(NCI)에서공동으로 연구진행 결과 더욱 명확하게 밝혀지고 있음.
1. When protein isn't completely digested it putrefies in the intestines and can
form nitrosamines which are carcinogenic. Digestive enzymes break down food so it can be absorbed more efficiently by the organs and keep undigested byproducts from forming
단백질이 장에서 완전히 소화되지 못할때 발암물질 '니트로사민'을 생성할 수 있음.
소화효소는 음식을 잘게 부숴 흡수되게 함. 2.Several integrative cancer specialists recommend taking enzymes with meals as well as between meals on an empty stomach.Digestive enzymes are thought to "digest" the coating of cancer cells, making them more vulnerable to the body's immune system and less likely to metastasize. (1)
몇몇의 암 전문가는 공복에 소화효소 복용을 권장함. 소화효소는 암세포의 코팅을 소화시켜
인체의 면역세포에 의해서 파괴되고 전이되지 못하게 하는 것으로 생각됨.
3. Enzymes also have anti-inflammatory properties which may affect the cancer process.
소화효소는 항염증 기능을 가지고 그것은 암세포 진행을 억제할 수 있음. Michael Schachter, MD, and Nicholas Gonzalez, MD, recommend supplemental enzymes for their cancer patients. Since the body makes many kinds of enzymes starting with the mouth and ending with the bowel, often a combination of digestive enzymes is recommended. The Wobenzyme and Wobe-Mugos brand of enzymes have been used since the 1940s by practitioners but check with your health practitioner for a brand and dosage recommendation.
Improving Absorption of Major and Micronutients "Many people diagnosed with cancer have digestion or intestinal tract disorders as well. Impaired digestion will greatly hinder a nutritional approach to treating cancer, if the nutrients can not be released from the food. ... Even raw foods, which contain many digestive enzymes to assist in their digestion, will be more thoroughly digested with less of the body's own resources with the use of digestive enzymes. So, the enzymes taken with meals do not have a direct effect upon a tumor, but assist the body in getting all of the nutrition out of all of the food for healing and restoring the body to normal function." (2)
암을 진단받은 많은 사람들이 소화와 장문제를 가지고 있음. 소화기능장애는 암치료에 심각한
장애를 초래함. .. 식사와 함께 복용하는 소화효소는 암에 직접적인 영향을 주지는 않지만
음식으로부터 영양소가 잘 흡수되게 하여 인체의 정상기능을 회복하게 함. Digestive Enzymes May Break Down Tumor Cell Blocking Factors
Digestive enzymes may break down blocking factors around cancer cells and allow NK cells to enter and attack cancer cells. According to Simon Yu, MD, pancreatic enzymes:
췌장소화효소는 암세포 주변의 방어요소를 파괴할 수 있음.
그리고 NK 세포가 암세포 안으로 들어가게 함.
1) Expose cancer cells' antigens by removing the fibrin coating, thus making cancer cells an easier target for the immune system.
피브린 코팅의 제거로 암세포의 항원이 노출되고 암세포가 인체면역세포에 의해 쉽게 파괴됨.
2) Reduce the adhesiveness of cancer and other cells, which makes it more difficult for cancer cells to adhere to the cell wall.
암과 다른 세포의 부착성이 줄어들게 하는데 이는 암세포가 다른 세포벽에 붙어 전이되는
것을 방지함.
3) Decrease levels of circulating immune complexes that tend to weaken the immune system's ability to respond to cancer.
순환하는 면역복합체의 감소는 면암세포에 반응하는 면역시스템의 약화를 야기함. Breast Cancer Outcome Supplementing with DigestiveEnzymes? Burton Goldberg's The Definitive Guide to Cancer reports that German physician, Dr. Max Wolf began using multi-enzyme formulas in 1949. In reviewing 107 women who had undergone mastectomies and used Wobenzymes, their survival rate was 84% after five years. Those using conventional therapy achieved only 43% -48% survival at five years.
1949년 버튼 골드버그는 107명의 유방암절제술을 한 환자에게 췌장소화효소 Wobenzyme를
사용하여 5년 생존율 84%. 다른 치료를 받은 환자는 5년 생존율 43%
Nutrition + Digestive Enzymes Patient Study
In the 1990s, Drs. Nicholas Gonzalez and Linda Isaacs conducted a pilot study of their patients with inoperable pancreatic cancer. Aggressive nutritional supplements, detox procedures, an organic diet, and large doses of digestive enzymes increased their patients' survival time over what would normally be expected for stages 111-1V pancreatic cancer. 25% survived for one year, and 10% survived for two years at all stages of pancreatic cancer. (3)
1990년 니콜라스 곤잘레스와 린다 아이작은 수술이 불가능한 췌장암 환자를 대상으로 연구
적극적인 영양보충제, 해독과정, organic diet, 고용량의 췌장소화효소를 사용하여...
Digestive Enzymes for Breast Cancer Therapy Side Effects In a German study, breast cancer patients undergoing surgery, radiation, chemo, or hormone therapy were broken into two groups. One group received oral enzymes, and the other group of patients did not receive any enzymes. The objective was to determine whether complementary treatment with oral enzymes can reduce typical disease- or therapy-associated signs and symptoms, such as gastrointestinal symptoms, mental symptoms, tumor pain, etc. Results: For all symptoms, except tumor pain, the improvement in symptom scores was larger in those women who received the oral enzymes than those women who received nothing. Thus, complementary treatment with oral enzymes improved the quality of life by reducing signs and symptoms of the disease and the side effects of the therapies. Also, epidemiological analysis provided evidence that the patients taking enzymes may also gain benefit in the length of survival by prolonging the time to cancer recurrence. (4)
CONCLUSION: "At the least, enzymes (oral enzyme supplementation) will
improve digestion and lessen the digestive burden on the body,
leaving more reserves for disease eradication. However, as the research indicates, the effect may be much greater than that, with the potential for direct anti-tumor activity." --Michael Donaldson.
1. Goldberg B., Alternative Medicine Definitive Guide to Cancer, Alternative Medicine.com Books 1997, p. 930 2. Donaldson M, Nutritional Cancer: A Review of the Evidence for an Anti-Cancer Diet, Nutr J 2004. 3. Gonzalez NJ and Isaacs LL., Evaluation of Pancreatic Proteolytic Enzyme Treatment of Adenocarcinoma of the Pancreas, with Nutritional and Detoxification Support, Nutrition and Cancer 1999. 4. Beuth J et al., Impact of Complementary Oral Enzyme Application on the Postoperative Treatment Results of Breast Cancer Patients - Results of an Epidemiological Multicentre Retrospective Cohort Study, Cancer Chemother Pharmacol 2001.
클릭클릭 - full text
Abstract
Historically, large doses of proteolytic enzymes, along with diet, nutritional supplements, and “detoxification”procedures, have been used in alternative therapies to treat all forms of cancer, without formal clinical studies to support their use.
A 2-year, unblinded, 1-treatment arm, 10-patient, pilot prospective case study was used to assess survival in patients suffering inoperable stage II–IV pancreatic adenocarcinoma treated with large doses of orally ingested pancreatic enzymes, nutritional supplements, “detoxification”procedures, and an organic diet. From January 1993 to April 1996 in the authors’ private practice, 10 patients with inoperable, biopsy-proven pancreatic adenocarcinoma were entered into the trial. After one patient dropped out, an 11th patient was added to the study (however, all 11 are considered in the data tabulation). Patients followed the treatment at home, under the supervision of the authors.
As of 12 January 1999, of 11 patients entered into the study, 9 (81%) survived one year, 5 (45%) survived two years, and at this time, 4 have survived three years. Two patients are alive and doing well: one at three years and the other at four years.
These results are far above the 25% survival at one year and 10% survival at two years for all stages of pancreatic adenocarcinoma reported in the National Cancer Data Base from 1995. This pilot study suggests that an aggressive nutritional therapy with large doses of pancreatic enzymes led to significantly increased survival over what would normally be expected for patients with inoperable pancreatic